Follow
Subrata Pore
Subrata Pore
Amity University, Noida
Verified email at amity.edu
Title
Cited by
Cited by
Year
The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR‐21 function by directly targeting its precursor
D Bose, G Jayaraj, H Suryawanshi, P Agarwala, SK Pore, R Banerjee, ...
Angewandte Chemie-International Edition 51 (4), 1019, 2012
1972012
Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism
KB Singh, SH Kim, ER Hahm, SK Pore, BL Jacobs, SV Singh
Carcinogenesis 39 (6), 826-837, 2018
462018
Inflammasomes are important mediators of prostatic inflammation associated with BPH
M Kashyap, S Pore, Z Wang, J Gingrich, N Yoshimura, P Tyagi
Journal of inflammation 12, 1-8, 2015
462015
Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants
A Sehrawat, R Roy, SK Pore, ER Hahm, SK Samanta, KB Singh, SH Kim, ...
Seminars in cancer biology 47, 147-153, 2017
412017
Disease subtype–independent biomarkers of breast cancer chemoprevention by the ayurvedic medicine phytochemical withaferin A
SK Samanta, A Sehrawat, SH Kim, ER Hahm, Y Shuai, R Roy, SK Pore, ...
JNCI: Journal of the National Cancer Institute 109 (6), djw293, 2017
392017
Structure− activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics
K Pal, SK Pore, S Sinha, R Janardhanan, D Mukhopadhyay, R Banerjee
Journal of medicinal chemistry 54 (7), 2378-2390, 2011
332011
BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivity
MP Kashyap, SK Pore, WC de Groat, CJ Chermansky, N Yoshimura, ...
American Journal of Physiology-Renal Physiology 315 (1), F45-F56, 2018
322018
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect
SK Pore, A Choudhary, B Rathore, A Ganguly, P Sujitha, CG Kumar, ...
Biomaterials 34 (28), 6804-6817, 2013
292013
Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate
SK Pore, ER Hahm, JD Latoche, CJ Anderson, Y Shuai, SV Singh
Carcinogenesis 39 (2), 134-145, 2018
202018
Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor
M Kashyap, S Pore, M Chancellor, N Yoshimura, P Tyagi
Life sciences 167, 98-104, 2016
202016
Advanced therapeutic directions to treat the underactive bladder
PP Smith, P Tyagi, GA Kuchel, S Pore, C Chermansky, M Chancellor, ...
International urology and nephrology 46, 35-44, 2014
182014
Engineered reversal of drug resistance in cancer cells—metastases suppressor factors as change agents
VK Yadav, A Kumar, A Mann, S Aggarwal, M Kumar, SD Roy, SK Pore, ...
Nucleic acids research 42 (2), 764-773, 2013
182013
Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo
KB Singh, ER Hahm, SK Pore, SV Singh
Molecular cancer therapeutics 18 (10), 1800-1810, 2019
162019
Spontaneous recovery of reflex voiding following spinal cord injury mediated by anti-inflammatory and neuroprotective factors
P Tyagi, K Kadekawa, M Kashyap, S Pore, N Yoshimura
Urology 88, 57-65, 2016
162016
Characterization of mammalian N-degrons and development of heterovalent inhibitors of the N-end rule pathway
Y Jiang, SK Pore, JH Lee, S Sriram, BK Mai, DH Han, P Agarwalla, ...
Chemical Science 4 (8), 3339-3346, 2013
132013
Urine chemokines indicate pathogenic association of obesity with BPH/LUTS
P Tyagi, SS Motley, M Kashyap, S Pore, J Gingrich, Z Wang, N Yoshimura, ...
International urology and nephrology 47, 1051-1058, 2015
122015
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer–Induced Osteolytic Bone Resorption
SK Pore, ER Hahm, SH Kim, KB Singh, L Nyiranshuti, JD Latoche, ...
Molecular cancer therapeutics 19 (2), 420-431, 2020
102020
Constitutive expression Of NGF And P75NTR affected by bladder distension and NGF antisense treatment
M Kashyap, S Pore, N Yoshimura, P Tyagi
Life sciences 148, 93-98, 2016
102016
Amine as a bottom-line functionality on DDS surface for efficient endosomal escape and further subcellular targets
SM Roy, S Barman, A Basu, T Ghatak, SK Pore, SK Ghosh, R Mukherjee, ...
Journal of Drug Delivery Science and Technology 71, 103303, 2022
62022
N‐end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expression
SK Pore, A Ganguly, S Sau, S Godeshala, AK Kanugula, R Ummanni, ...
Journal of Cellular Biochemistry 121 (1), 804-815, 2020
32020
The system can't perform the operation now. Try again later.
Articles 1–20